AzTrials
AzTrials

Autism Spectrum DisorderNCT07330219

The Effect of Fully Immersive Virtual Reality Technology Combined With Psychological and Behavioral Intervention on Autism Spectrum Disorder

A study testing Fully Immersive Virtual Reality Training and Psychological and Behavioral Intervention in people with Autism Spectrum Disorder, run by Tongren Hongxin Kangxin Traditional Chinese Medicine Hospital, Guizhou Province at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To explore the effects of immersive virtual reality technology combined with psychological and behavioral intervention on children with autism. Methods: A retrospective study was conducted on the clinical data of 120 children with autism admitted to our hospital from January 2024 to October 2024. Read more about this study

Who is it for?
Ages 2 to 12 years
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Fully Immersive Virtual Reality Training and Psychological and Behavioral Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteChina
Study dates
1 Feb 2024to 30 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Clinical diagnosis of autism spectrum disorder (ASD) according to DSM-5 criteria;
  • Age between 2 and 12 years;
  • Complete clinical and assessment data available.

Who cannot join

  • Diagnosis of schizophrenia or other psychotic disorders;
  • Severe intellectual disability preventing completion of assessments;
  • History of epilepsy or uncontrolled seizure disorders;
  • Significant visual or auditory impairment;
  • History of intracranial surgery or implantation of metallic foreign bodies.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Hongxinkang New Traditional Chinese Medicine Hospital, Tongren

    Tongren, Guizhou, 554300

Other trials in China

About this study

To explore the effects of immersive virtual reality technology combined with psychological and behavioral intervention on children with autism. Methods: A retrospective study was conducted on the clinical data of 120 children with autism admitted to our hospital from January 2024 to October 2024. 58 children received psychological and behavioral intervention alone (control group), while 62 children received psychological and behavioral intervention combined with immersive virtual reality technology (study group). Disease severity (CARS),

Read the detailed description

This is a single-center, retrospective interventional study evaluating the effects of fully immersive virtual reality combined with psychological and behavioral intervention in children with autism spectrum disorder. Clinical data were retrospectively collected from February 2024 to October 2024. Outcomes were assessed using standardized behavioral and developmental scales.

Being tested
Fully Immersive Virtual Reality Training, Psychological and Behavioral Intervention
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fully Immersive Virtual Reality TrainingBehavioural

    Fully immersive virtual reality (FIVR) training is delivered using head-mounted display devices. The training includes structured virtual scenarios targeting social interaction, communication skills, and sensory regulation. Each session lasts 20-60 minutes, delivered 3-5 times per week for 12 weeks, with individualized adjustment based on participant tolerance and performance.

  • Psychological and Behavioral InterventionBehavioural

    Psychological and behavioral intervention (PBI) includes language training, sensory integration training, group-based activities, individualized behavioral training, family-based training, and psychological support. Sessions are conducted multiple times per week over a 12-week period according to a standardized rehabilitation protocol.

Study groups in NCT07330219
Study groupRoleWhat they receive
Fully Immersive Virtual Reality Combined With Psychological and Behavioral InterventionExperimentalParticipants receive fully immersive virtual reality (FIVR) training combined with standard psychological and behavioral intervention (PBI). The intervention lasts for 12 weeks. FIVR is delivered 3-5 times per week in addition to routine PBI.
Receives: Behavioral: Fully Immersive Virtual Reality Training; Behavioral: Psychological and Behavioral Intervention
Psychological and Behavioral Intervention OnlyActive comparatorParticipants receive standard psychological and behavioral intervention (PBI) alone for 12 weeks, including language training, sensory integration training, group activities, individualized training, family-based training, and psychological support.
Receives: Behavioral: Psychological and Behavioral Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Childhood Autism Rating Scale (CARS) Total Score

    The Childhood Autism Rating Scale (CARS) is a clinician-rated assessment consisting of 15 items, each scored from 1 to 4, with a total score range from 15 to 60.

    Higher scores indicate more severe autism-related symptoms (worse outcome). The outcome is defined as the change in total CARS score from baseline to the end of the 12-week intervention period.

    Measured: Baseline and 12 weeks after initiation of intervention

Secondary outcomes (3)
  1. Change in Aberrant Behavior Checklist (ABC) Total Score

    The Aberrant Behavior Checklist (ABC) is a standardized caregiver-rated scale assessing problem behaviors in children with autism spectrum disorder across five domains.

    The total score ranges from 0 to 158, with higher scores indicating more severe behavioral problems (worse outcome).

    The outcome is defined as the change in ABC total score from baseline to 12 weeks.

    Measured: Baseline and 12 weeks

  2. Change in Psychoeducational Profile-Third Edition (PEP-3) Total Score

    The Psychoeducational Profile-Third Edition (PEP-3) is a standardized developmental assessment evaluating cognitive, language, and adaptive functioning in children with autism spectrum disorder.

    Higher scores indicate better developmental functioning (better outcome). The outcome is defined as the change in PEP-3 total score from baseline to 12 weeks.

    Measured: Baseline and 12 weeks

  3. Parental Satisfaction With Intervention

    Parental satisfaction with the intervention is assessed using the Newcastle Satisfaction with Nursing Scales (NSNS).

    The scale measures satisfaction across multiple domains, with higher scores indicating greater satisfaction (better outcome).

    Overall satisfaction is assessed at the end of the 12-week intervention period.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2026
  2. Study start1 Feb 2024
  3. Primary completion30 Oct 2024
  4. Study completion30 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07330219
Sponsor's protocol ID
2024-1-1
Status last verified
Jan 2026
First submitted
26 Dec 2025
Last updated
27 Jan 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Li N, Tian M, Yang Y, Liu Z, Sun L, Li B. The effect of fully immersive virtual reality technology combined with psychological and behavioral intervention on autism spectrum disorder. BMC Psychol. 2025 Oct 9;13(1):1120. doi: 10.1186/s40359-025-03460-y.

    PubMed 41068944

Questions about this trial

What is this clinical trial studying?

A study testing Fully Immersive Virtual Reality Training and Psychological and Behavioral Intervention in people with Autism Spectrum Disorder, run by Tongren Hongxin Kangxin Traditional Chinese Medicine Hospital, Guizhou Province at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Childhood Autism Rating Scale (CARS) Total Score (time frame: Baseline and 12 weeks after initiation of intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07330219, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in